The Epidemiology of Parkinson's Disease: A Case-Control Study of Young-Onset and Old-Onset Patients

Archives of Neurology

Volumn 48, Issue 9, 1991, Pages 903-907

  Stern, Matthew ^a   Dulaney, Eugene ^a   Gruber, Stephen B ^a   Golbe, Larry ^a   Bergen, Mary ^a   Hurtig, Howard ^a   Gollomp, Steve ^b   Stolley, Paul ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTOXIN;

ADULT; ARTICLE; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; HEAD INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; BRAIN INJURIES; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; INSECTICIDES; MALE; MIDDLE AGE; PARKINSON DISEASE; PESTICIDES; RISK FACTORS; RURAL POPULATION; SMOKING; SUPPORT, NON-U.S. GOV'T;

EID: 0026079542     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1991.00530210029018     Document Type: Article

References (48)

1. Calne DB, Langston WJ. Hypothesis: the aetiology of Parkinson's disease. Lancet. 1984;2:1457-1458.
2. Calne DB. Current concepts on the etiology of Parkinson's disease. Mov Disord. 1989;4(suppl): S11-S14.
3. Burns RS, LeWitt PA, Ebert MH, et al. The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med. 1985;312:1418-1421.
4. Langston JW, Ballard P, Tetrud JW, et al. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:9789-9790.
5. Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med. 1989;213:1364-1371.
6. Koller W, Vetere-Overfield RN, Gray C, et al. Environmental risk factors in Parkinson's disease. Neurology. 1990;40:1218-1221.
7. Schoenberg BS. Environmental risk factors for Parkinson's disease: the epidemiologic evidence. Can J Neurol Sci. 1987;14:407-413.
8. Tanner CM. The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 1989;12:49-54.
9. Koller WC, Dolezal J, Chin T, Hassanein RS, Weldon G. Environmental risk factors in Parkinson's disease. Neurology. 1989;39(suppl):285.
10. Rajput AH, Uitti RJ, Stern W, et al. Early onset Parkinson's disease in Saskatchewan: environmental considerations for etiology. Can J Neurol Sci. 1986;13:212-216.
11. Tanner CM, Chen B, Wang W-Z, et al. Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci. 1987;14:419-423.
12. Kelsey JL, Thompson WD, Evans AS. Methods in Observational Epidemiology. New York, NY: Oxford University Press; 1986.
13. Breslow NE, Day NE. The Analysis of Case-Control Studies. Lyons, France: International Agency for Research on Cancer: 1980;1. Statistical Methods in Cancer Research.
14. Barbeau A, Roy M, Bernier G, et al. Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci. 1987;14:36-41.
15. Barbeau A, Roy M, Cloutier T, et al. Environmental and genetic factors in aetiology of Parkinson's disease. Adv Neurol. 1986;45:299-306.
16. Lux WE, Kurtzke JF. Is Parkinson's disease acquired? Evidence from a geographic comparison with multiple sclerosis. Neurology. 1987;37:467-471.
17. Tanner CM, Chen B, Wang W-Z, et al. Environmental factors and Parkinson's disease: a case-control study in China. Neurology. 1989;39:660-664.
18. Ho SC, Woo J, Lee C-M. Epidemiologic study of Parkinson's disease in Hong Kong. Neurology. 1989;39:1314-1318.
19. Rajput AH, Uitti RJ, Stern W, et al. Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease. Can J Neurol Sci. 1987;14:414-418.
20. Rajput AH, Vitti RJ. Paraquat and Parkinson's disease. Neurology. 1987;33:1820.
21. Meador KJ, Meador MP, Loring DS, et al. Neuroepidemiology of Parkinson's disease. Neurology. 1987;37(suppl 1):120.
22. Bharucha NE, Stokes LS, Schoenberg BS, et al. A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors. Neurology. 1986;36:284-288.
23. Wong G, Gray C, Koller W. Environmental factors in siblings with Parkinson's disease. Ann Neurol. 1989;26:162.
24. McGeer P, Itagaki S, Akiyama H, McGeer E. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol. 1988;24:574-576.
25. Scherman D, Desnos C, Darchen F, et al. Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol. 1989;26:551-557.
26. Riederer P, Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease. J Neurol Transm. 1976;38:277-301.
27. Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young and old-onset Parkinson's disease. Neurology. 1988;38:1402-1406.
28. Baron JA. Cigarette smoking and Parkinson's disease. Neurology. 1986;36:1490-1496.
29. Aceto MD, Martin BR. Central actions of nicotine. Med Res Rev. 1982;2:43-62.
30. Balfour DJK. The effects of nicotine on brain neurotransmitter systems. In: Balfour DJK, ed. Nicotine and the Tobacco Smoking Habit. Oxford, England: Pergamon Press; 1984.
31. Lichtensteiger W, Hefti F, Felix D, et al. Stimulation of nigrostriatal dopamine neurones by nicotine. Neuropharmacology. 1982;21:963-968.
32. Clarke PBS, Hommer DW, Pert A, Skirboll LR. Electrophysiological actions of nicotine on substantia nigra single units. Br J Pharmacol. 1985;85:827-835.
33. Calne DB. Current views of Parkinson's disease. Can J Neurol Neurol Sci. 1983;10:11-15.
34. Testa B, Naylor R, Costall B, Jenner P, Marsden CD. Does an endogenous methylpyridinium analogue cause Parkinson's disease? J Pharm Pharmacol. 1985;37:679-680.
35. Golbe LI, Cody RA, Duvoisin RC. Smoking and Parkinson's disease: search for a dose-response relationship. Arch Neurol. 1986;43:774-778.
36. Rajput AH, Offord KP, Beard CM, Kurland LT. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology. 1987;37:226-232.
37. Parkinson J. Essay on the Shaking Palsy. London, England: Whittingham and Rowland, for Sherwood, Neely and Jones; 1817.
38. Factor SA, Sanchez-Ramos J, Weiner WJ. Trauma as an etiology of parkinsonism: a historical review of the concept. Mov Disord. 1988;3:30-36.
39. Ward CD, Duvoisin RC, Luce SE, et al. Parkinson's disease in 65 pairs of twins and a set of quadruplets. Neurology. 1983;33:815-824.
40. Koller WC, Wong GF, Lang A. Post-traumatic movement disorders: review. Mov Disord. 1989;4:20-36.
41. Factor SA, Weiner WJ. Head trauma and Parkinson's disease. Mov Disord. 1990;5(suppl):13.
42. Corsellis J, Burton C, Freeman-Browne D. The aftermath of boxing. Psychol Med. 1973;3:270-303.
43. Amaduci LA, Fratiglioni L, Rocca WA, et al. Risk factors for Alzheimer's disease (AD): a case-control study on an Italian population. Neurology. 1986;36:209-211.
44. French LR, Schuman LM, Mortimer JA, et al. A case-control study of dementia of the Alzheimer type. Am J Epidemiol. 1985;121:414-421.
45. Gallagher JP, Sanders M. Trauma and amyotrophic lateral sclerosis: a report of 78 patients. Acta Neurol Scand. 1987;75:145-150.
46. Sienko DG, Davis JP, Taylor JA, Brooks BR. Amyotrophic lateral sclerosis: a case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol. 1990;47:38-41.
47. Roberts GW, Allsop D, Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatry. 1990;53:373-378.
48. Rudelli R, Strom JO, Welch PT, et al. Posttraumatic premature Alzheimer's disease: neuropathologic findings and pathogenetic considerations. Arch Neurol. 1982;39:570-575.